Expert Consulting and Expert Witness Services
-
Upload
lekshmisalim -
Category
Documents
-
view
223 -
download
0
Transcript of Expert Consulting and Expert Witness Services
-
8/14/2019 Expert Consulting and Expert Witness Services
1/37
http://www.pharmainfo.net/http://www.intota.com/rfp/rfp.asp?perID=724591http://www.pharmainfo.net/http://www.intota.com/http://www.intota.com/http://www.intota.com/rfp/rfp.asphttp://www.intota.com/help/default.asphttp://www.intota.com/aboutus/AboutUs.asphttp://www.intota.com/help/contact_us.asphttp://www.intota.com/SearchTips.asphttp://www.intota.com/help/default.asphttp://www.intota.com/help/privacy.asphttp://www.pharmainfo.net/http://www.pharmainfo.net/infohttp://www.pharmainfo.net/communityhttp://www.pharmainfo.net/pharmaceuticalarticleshttp://www.pharmainfo.net/e-journalhttp://www.pharmainfo.net/contacthttp://www.pharmainfo.net/userhttp://www.pharmainfo.net/http://www.pharmainfo.net/latest-reviewshttp://www.pharmainfo.net/volumes-and-issues/2007/vol-5-issue-6http://www.pharmainfo.net/volumes-and-issues/2007 -
8/14/2019 Expert Consulting and Expert Witness Services
2/37
-
8/14/2019 Expert Consulting and Expert Witness Services
3/37
-
8/14/2019 Expert Consulting and Expert Witness Services
4/37
http://www.fda.gov/ -
8/14/2019 Expert Consulting and Expert Witness Services
5/37
http://www.fda.gov/ -
8/14/2019 Expert Consulting and Expert Witness Services
6/37
-
8/14/2019 Expert Consulting and Expert Witness Services
7/37
http://www.fda.gov/default.htmhttp://www.fda.gov/Drugs/default.htmhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/default.htmhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/default.htmhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/default.htmhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/default.htmhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm053133.htmhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Investigational%20New%20Drug%20Process%23Investigational%20New%20Drug%20Processhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Introduction%23Introductionhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Definitions%23Definitionshttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Types%20of%20INDs%23Types%20of%20INDshttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Phases%20of%20an%20Investigation%23Phases%20of%20an%20Investigationhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Investigational%20New%20Drug%20Application%20FAQ's%23Investigational%20New%20Drug%20Application%20FAQ'shttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#pre-clinical%20studies?%23pre-clinical%20studies?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#IND%23INDhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#submit%20an%20IND?%23submit%20an%20IND?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#forms?%23forms?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Instructions%23Instructionshttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#IND%20number?%23IND%20number?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#When%20can%20I%20start%20clinical%20trials?%23When%20can%20I%20start%20clinical%20trials?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Form%201572?%23Form%201572?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#What%20is%20an%20IRB?%23What%20is%20an%20IRB?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#IRB%20approval?%23IRB%20approval?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#IRB%20approval?%23IRB%20approval?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#marketed%20product%23marketed%20producthttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#marketed%20product%23marketed%20producthttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#informed%20consent?%23informed%20consent?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#contacts%23contactshttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#contacts%23contacts -
8/14/2019 Expert Consulting and Expert Witness Services
8/37
http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=2004_register&docid=fr06ap04-20.pdfhttp://frwebgate.access.gpo.gov/cgi-bin/get-cfr.cgi?TITLE=21&PART=312&SECTION=23&YEAR=1999&TYPE=TEXThttp://frwebgate.access.gpo.gov/cgi-bin/get-cfr.cgi?TITLE=21&PART=312&SECTION=34&YEAR=1999&TYPE=TEXThttp://frwebgate.access.gpo.gov/cgi-bin/get-cfr.cgi?TITLE=21&PART=312&SECTION=34&YEAR=1999&TYPE=TEXT -
8/14/2019 Expert Consulting and Expert Witness Services
9/37
-
8/14/2019 Expert Consulting and Expert Witness Services
10/37
-
8/14/2019 Expert Consulting and Expert Witness Services
11/37
http://www.fda.gov/AboutFDA/CentersOffices/CDER/ucm090301.htmhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/InvestigationalNewDrugINDApplication/ucm071098.htmhttp://www.fda.gov/downloads/AboutFDA/ReportsManualsForms/Forms/UCM083548.pdf -
8/14/2019 Expert Consulting and Expert Witness Services
12/37
http://www.fda.gov/Drugs/default.htmmailto:[email protected] -
8/14/2019 Expert Consulting and Expert Witness Services
13/37
http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069901.htmhttp://www.fda.gov/AboutFDA/CentersOffices/CDER/ContactCDER/CDEROmbudsman/default.htmhttp://www.aidsinfo.nih.gov/http://www.fda.gov/AboutFDA/AboutThisWebsite/WebsitePolicies/ViewingFiles/default.htmhttp://www.fda.gov/default.htmhttp://www.fda.gov/AboutFDA/default.htmhttp://www.fda.gov/AboutFDA/ContactFDA/default.htmhttp://www.fda.gov/SiteIndex/default.htmhttp://www.fda.gov/SiteMap/default.htmhttp://www.fda.gov/AboutFDA/AboutThisWebsite/default.htmhttp://www.fda.gov/RegulatoryInformation/FOI/default.htmhttp://www.fda.gov/AboutFDA/AboutThisWebsite/Accessibility/default.htmhttp://www.fda.gov/AboutFDA/WorkingatFDA/NoFearAct/default.htmhttp://www.fda.gov/CombinationProducts/default.htmhttp://www.fda.gov/AdvisoryCommittees/default.htmhttp://www.fda.gov/ScienceResearch/default.htmhttp://www.fda.gov/RegulatoryInformation/default.htmhttp://www.fda.gov/Safety/default.htmhttp://www.fda.gov/EmergencyPreparedness/default.htmhttp://www.fda.gov/InternationalPrograms/default.htmhttp://www.fda.gov/NewsEvents/default.htmhttp://www.fda.gov/Training/default.htmhttp://www.fda.gov/ICECI/default.htmhttp://www.fda.gov/ForFederalStateandLocalOfficials/default.htmhttp://www.fda.gov/ForConsumers/default.htmhttp://www.fda.gov/ForIndustry/default.htmhttp://www.fda.gov/ForHealthProfessionals/default.htm -
8/14/2019 Expert Consulting and Expert Witness Services
14/37
http://www.fda.gov/default.htmhttp://www.hhs.gov/http://www.hhs.gov/http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#main%23mainhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#search%23searchhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#fda-topmenu%23fda-topmenuhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#section-menu%23section-menuhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#footer%23footerhttp://www.fda.gov/SiteIndex/default.htmhttp://www.fda.gov/default.htmhttp://www.fda.gov/Food/default.htmhttp://www.fda.gov/Drugs/default.htmhttp://www.fda.gov/MedicalDevices/default.htmhttp://www.fda.gov/BiologicsBloodVaccines/default.htmhttp://www.fda.gov/AnimalVeterinary/default.htmhttp://www.fda.gov/Cosmetics/default.htmhttp://www.fda.gov/Radiation-EmittingProducts/default.htmhttp://www.fda.gov/TobaccoProducts/default.htmhttp://www.addthis.com/bookmark.php?v=152&pub=fdamainhttp://www.accessdata.fda.gov/scripts/email/email.cfm -
8/14/2019 Expert Consulting and Expert Witness Services
15/37
http://www.fda.gov/default.htmhttp://www.fda.gov/Drugs/default.htmhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/default.htmhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/default.htmhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/default.htmhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/default.htmhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm053133.htmhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Investigational%20New%20Drug%20Process%23Investigational%20New%20Drug%20Processhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Introduction%23Introductionhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Definitions%23Definitionshttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Types%20of%20INDs%23Types%20of%20INDshttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Phases%20of%20an%20Investigation%23Phases%20of%20an%20Investigationhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Investigational%20New%20Drug%20Application%20FAQ's%23Investigational%20New%20Drug%20Application%20FAQ'shttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#pre-clinical%20studies?%23pre-clinical%20studies?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#IND%23INDhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#submit%20an%20IND?%23submit%20an%20IND?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#forms?%23forms?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Instructions%23Instructionshttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#IND%20number?%23IND%20number?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#When%20can%20I%20start%20clinical%20trials?%23When%20can%20I%20start%20clinical%20trials?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Form%201572?%23Form%201572?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#What%20is%20an%20IRB?%23What%20is%20an%20IRB?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#IRB%20approval?%23IRB%20approval?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#IRB%20approval?%23IRB%20approval?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#marketed%20product%23marketed%20producthttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#marketed%20product%23marketed%20producthttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#informed%20consent?%23informed%20consent?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#contacts%23contactshttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#contacts%23contacts -
8/14/2019 Expert Consulting and Expert Witness Services
16/37
http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=2004_register&docid=fr06ap04-20.pdfhttp://frwebgate.access.gpo.gov/cgi-bin/get-cfr.cgi?TITLE=21&PART=312&SECTION=23&YEAR=1999&TYPE=TEXThttp://frwebgate.access.gpo.gov/cgi-bin/get-cfr.cgi?TITLE=21&PART=312&SECTION=34&YEAR=1999&TYPE=TEXThttp://frwebgate.access.gpo.gov/cgi-bin/get-cfr.cgi?TITLE=21&PART=312&SECTION=34&YEAR=1999&TYPE=TEXT -
8/14/2019 Expert Consulting and Expert Witness Services
17/37
-
8/14/2019 Expert Consulting and Expert Witness Services
18/37
-
8/14/2019 Expert Consulting and Expert Witness Services
19/37
http://www.fda.gov/AboutFDA/CentersOffices/CDER/ucm090301.htmhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/InvestigationalNewDrugINDApplication/ucm071098.htmhttp://www.fda.gov/downloads/AboutFDA/ReportsManualsForms/Forms/UCM083548.pdf -
8/14/2019 Expert Consulting and Expert Witness Services
20/37
http://www.fda.gov/Drugs/default.htmmailto:[email protected] -
8/14/2019 Expert Consulting and Expert Witness Services
21/37
http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069901.htmhttp://www.fda.gov/AboutFDA/CentersOffices/CDER/ContactCDER/CDEROmbudsman/default.htmhttp://www.aidsinfo.nih.gov/http://www.fda.gov/AboutFDA/AboutThisWebsite/WebsitePolicies/ViewingFiles/default.htmhttp://www.fda.gov/default.htmhttp://www.fda.gov/AboutFDA/default.htmhttp://www.fda.gov/AboutFDA/ContactFDA/default.htmhttp://www.fda.gov/SiteIndex/default.htmhttp://www.fda.gov/SiteMap/default.htmhttp://www.fda.gov/AboutFDA/AboutThisWebsite/default.htmhttp://www.fda.gov/RegulatoryInformation/FOI/default.htmhttp://www.fda.gov/AboutFDA/AboutThisWebsite/Accessibility/default.htmhttp://www.fda.gov/AboutFDA/WorkingatFDA/NoFearAct/default.htmhttp://www.fda.gov/CombinationProducts/default.htmhttp://www.fda.gov/AdvisoryCommittees/default.htmhttp://www.fda.gov/ScienceResearch/default.htmhttp://www.fda.gov/RegulatoryInformation/default.htmhttp://www.fda.gov/Safety/default.htmhttp://www.fda.gov/EmergencyPreparedness/default.htmhttp://www.fda.gov/InternationalPrograms/default.htmhttp://www.fda.gov/NewsEvents/default.htmhttp://www.fda.gov/Training/default.htmhttp://www.fda.gov/ICECI/default.htmhttp://www.fda.gov/ForFederalStateandLocalOfficials/default.htmhttp://www.fda.gov/ForConsumers/default.htmhttp://www.fda.gov/ForIndustry/default.htmhttp://www.fda.gov/ForHealthProfessionals/default.htm -
8/14/2019 Expert Consulting and Expert Witness Services
22/37
http://www.allp.com/drug_dev.htmhttp://www.mindbranch.com/products/R198-014http://www.businessworldindia.com/http://www.pubs.acs.org/cen/coverstory/8004/8004pharmaceuticals.htmlhttp://www.pharmaquality.com/Cover%20Story5.htmhttp://www.fda.gov/cder/handbook/index.htm -
8/14/2019 Expert Consulting and Expert Witness Services
23/37
http://www.allp.com/drug_dev.htmhttp://www.fda.gov/cder/regulatory/applications/ind_page_1.htmhttp://www.fda.gov/cder/regulatory/applications/NDA.htmmailto:[email protected] -
8/14/2019 Expert Consulting and Expert Witness Services
24/37
http://www.pharmainfo.net/http://www.pharmainfo.net/http://www.pharmainfo.net/infohttp://www.pharmainfo.net/communityhttp://www.pharmainfo.net/pharmaceuticalarticleshttp://www.pharmainfo.net/e-journalhttp://www.pharmainfo.net/contacthttp://www.pharmainfo.net/userhttp://www.pharmainfo.net/http://www.pharmainfo.net/latest-reviews -
8/14/2019 Expert Consulting and Expert Witness Services
25/37
http://www.pharmainfo.net/volumes-and-issues/2007/vol-5-issue-6http://www.pharmainfo.net/volumes-and-issues/2007 -
8/14/2019 Expert Consulting and Expert Witness Services
26/37
-
8/14/2019 Expert Consulting and Expert Witness Services
27/37
http://www.fda.gov/ -
8/14/2019 Expert Consulting and Expert Witness Services
28/37
http://www.fda.gov/ -
8/14/2019 Expert Consulting and Expert Witness Services
29/37
-
8/14/2019 Expert Consulting and Expert Witness Services
30/37
http://www.allp.com/drug_dev.htmhttp://www.mindbranch.com/products/R198-014http://www.businessworldindia.com/http://www.pubs.acs.org/cen/coverstory/8004/8004pharmaceuticals.htmlhttp://www.pharmaquality.com/Cover%20Story5.htmhttp://www.fda.gov/cder/handbook/index.htmhttp://www.allp.com/drug_dev.htmhttp://www.fda.gov/cder/regulatory/applications/ind_page_1.htmhttp://www.fda.gov/cder/regulatory/applications/NDA.htm -
8/14/2019 Expert Consulting and Expert Witness Services
31/37
mailto:[email protected] -
8/14/2019 Expert Consulting and Expert Witness Services
32/37
http://www.pharmainfo.net/deepkaushikhttp://www.pharmainfo.net/mukeshgohelhttp://www.pharmainfo.net/pharmaglowhttp://www.pharmainfo.net/pppc02http://www.pharmainfo.net/pharmacyschoolshttp://www.pharmainfo.net/bloghttp://www.pharmainfo.net/pharmacists-zone/fpgee-practice-questions-and-answershttp://www.pharmainfo.net/pharmaglow/pharmindia-competitions/2nd-group-discussion-competition/winnershttp://www.pharmainfo.net/reviews/%20/pharmaglow/powerpoint-presentation-competitions/pppc-03http://www.pharmainfo.net/reviews/spray-drying-reviewhttp://www.pharmainfo.net/mukeshgohelhttp://www.pharmainfo.net/reviews/functional-foodnutraceuticals-regulation-indiahttp://www.pharmainfo.net/deepkaushikhttp://www.pharmainfo.net/reviews/food-safety-and-standards-act-2006-paradigm-shift-indian-regulatory-scenariohttp://www.pharmainfo.net/reviews/food-safety-and-standards-act-2006-paradigm-shift-indian-regulatory-scenario -
8/14/2019 Expert Consulting and Expert Witness Services
33/37
http://www.pharmainfo.net/amolsmalpanihttp://www.pharmainfo.net/atul-kadamhttp://www.pharmainfo.net/shantibhushanhttp://www.pharmainfo.net/prabakar75http://www.pharmainfo.net/anand-shahhttp://www.pharmainfo.net/mpalthurhttp://www.pharmainfo.net/mpalthurhttp://www.pharmainfo.net/reviews/film-coating-technology-overviewhttp://www.pharmainfo.net/anand-shahhttp://www.pharmainfo.net/reviews/pharmaceutical-micropellets-overviewhttp://www.pharmainfo.net/prabakar75http://www.pharmainfo.net/reviews/cancer-therapy-ayurveda-systemic-reviewhttp://www.pharmainfo.net/shantibhushanhttp://www.pharmainfo.net/reviews/rational-drug-use-concern-healthcare-professionalshttp://www.pharmainfo.net/atul-kadamhttp://www.pharmainfo.net/reviews/promising-novel-approaches-oral-delivery-poorly-soluble-drugs -
8/14/2019 Expert Consulting and Expert Witness Services
34/37
http://www.pharmainfo.net/mohammad-ruhal-ainhttp://www.pharmainfo.net/apexa-patelhttp://www.pharmainfo.net/amolsmalpanihttp://www.pharmainfo.net/reviews/preformulation-and-quality-overall-summary-regulatory-insightshttp://www.pharmainfo.net/apexa-patelhttp://www.pharmainfo.net/reviews/phytopharmaceuticals-extensive-reviewhttp://www.pharmainfo.net/mohammad-ruhal-ainhttp://www.pharmainfo.net/pharmaglowhttp://www.pharmainfo.net/pppc02http://www.pharmainfo.net/pharmacyschoolshttp://www.pharmainfo.net/bloghttp://www.pharmainfo.net/pharmacists-zone/fpgee-practice-questions-and-answershttp://www.pharmainfo.net/pharmaglow/pharmindia-competitions/2nd-group-discussion-competition/winnershttp://www.pharmainfo.net/reviews/%20/pharmaglow/powerpoint-presentation-competitions/pppc-03http://www.pharmainfo.net/reviews/spray-drying-review -
8/14/2019 Expert Consulting and Expert Witness Services
35/37
http://www.pharmainfo.net/prabakar75http://www.pharmainfo.net/anand-shahhttp://www.pharmainfo.net/mpalthurhttp://www.pharmainfo.net/deepkaushikhttp://www.pharmainfo.net/mukeshgohelhttp://www.pharmainfo.net/mukeshgohelhttp://www.pharmainfo.net/reviews/functional-foodnutraceuticals-regulation-indiahttp://www.pharmainfo.net/deepkaushikhttp://www.pharmainfo.net/reviews/food-safety-and-standards-act-2006-paradigm-shift-indian-regulatory-scenariohttp://www.pharmainfo.net/reviews/food-safety-and-standards-act-2006-paradigm-shift-indian-regulatory-scenariohttp://www.pharmainfo.net/mpalthurhttp://www.pharmainfo.net/reviews/film-coating-technology-overviewhttp://www.pharmainfo.net/anand-shahhttp://www.pharmainfo.net/reviews/pharmaceutical-micropellets-overviewhttp://www.pharmainfo.net/prabakar75http://www.pharmainfo.net/reviews/cancer-therapy-ayurveda-systemic-review -
8/14/2019 Expert Consulting and Expert Witness Services
36/37
http://www.biomedcentral.com/info/mediainformation/http://www.pharmainfo.net/mohammad-ruhal-ainhttp://www.pharmainfo.net/apexa-patelhttp://www.pharmainfo.net/amolsmalpanihttp://www.pharmainfo.net/atul-kadamhttp://www.pharmainfo.net/shantibhushanhttp://www.pharmainfo.net/shantibhushanhttp://www.pharmainfo.net/reviews/rational-drug-use-concern-healthcare-professionalshttp://www.pharmainfo.net/atul-kadamhttp://www.pharmainfo.net/reviews/promising-novel-approaches-oral-delivery-poorly-soluble-drugshttp://www.pharmainfo.net/amolsmalpanihttp://www.pharmainfo.net/reviews/preformulation-and-quality-overall-summary-regulatory-insightshttp://www.pharmainfo.net/apexa-patelhttp://www.pharmainfo.net/reviews/phytopharmaceuticals-extensive-reviewhttp://www.pharmainfo.net/mohammad-ruhal-ainhttp://www.biomedcentral.com/abstracts/AGAH/1/op011/#content%23content -
8/14/2019 Expert Consulting and Expert Witness Services
37/37